Home RxNorm 1947131 triamcinolone acetonide 32 MG Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1947131
RxNorm name triamcinolone acetonide 32 MG Injection
Display name Triamcinolone (Injectable)
Full name triamcinolone acetonide 32 MG Injection
Term type SCD
Status Active
Strength 32 mg
Dose form Injection
Route Injectable
Updated 2026-10-30 15:34:02 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 112017
Active start 112017
Multiple ingredient NO
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength triamcinolone acetonide 32 MG / 1 EACH triamcinolone triamcinolone acetonide
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Zilretta TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION Pacira Pharmaceuticals, Inc. cd5c4673-21f2-4126-9556-da847b3a228b 2026-06-03 Warnings, Adverse reactions Exact identifier rxcui: 1947131
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective cd5c4673-21f2-4126-9556-da847b3a228b triamcinolone acetonide 32 MG Extended-Release Injection [PSN] · triamcinolone acetonide 32 MG Injection [SCD] 2 6 These highlights do not include all the information needed to use ZILRETTA safely and effectively. See full prescribing information for ZILRETTA. ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension), for intra-articular use Initial U.S. Approval: 1957 20260402
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC C05AA Corticosteroids ATC1-4 triamcinolone ATC R01AD Corticosteroids ATC1-4 triamcinolone ATC A01AC Corticosteroids for local oral treatment ATC1-4 triamcinolone ATC D07AB Corticosteroids, moderately potent (group II) ATC1-4 triamcinolone ATC D07XB Corticosteroids, moderately potent, other combinations ATC1-4 triamcinolone ATC S01BA Corticosteroids, plain ATC1-4 triamcinolone ATC R03BA Glucocorticoids ATC1-4 triamcinolone ATC H02AB Glucocorticoids ATC1-4 triamcinolone FDASPL N0000175576 Corticosteroid EPC has_epc triamcinolone FDASPL N0000175576 Corticosteroid EPC has_epc triamcinolone acetonide FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa triamcinolone acetonide FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa triamcinolone MEDRT D014221 Triamcinolone CHEM has_ingredient triamcinolone MEDRT D014222 Triamcinolone Acetonide CHEM has_ingredient triamcinolone acetonide MEDRT D000309 Adrenal Insufficiency DISEASE may_treat triamcinolone acetonide MEDRT D000309 Adrenal Insufficiency DISEASE may_treat triamcinolone MEDRT D000743 Anemia, Hemolytic DISEASE may_treat triamcinolone acetonide MEDRT D000743 Anemia, Hemolytic DISEASE may_treat triamcinolone MEDRT D015210 Arthritis, Gouty DISEASE may_prevent triamcinolone MEDRT D015210 Arthritis, Gouty DISEASE may_prevent triamcinolone acetonide MEDRT D001172 Arthritis, Rheumatoid DISEASE may_prevent triamcinolone MEDRT D001172 Arthritis, Rheumatoid DISEASE may_prevent triamcinolone acetonide MEDRT D001249 Asthma DISEASE may_prevent triamcinolone MEDRT D001249 Asthma DISEASE may_prevent triamcinolone acetonide MEDRT D001607 Berylliosis DISEASE may_treat triamcinolone acetonide MEDRT D001607 Berylliosis DISEASE may_treat triamcinolone MEDRT D001986 Bronchial Spasm DISEASE may_treat triamcinolone MEDRT D001986 Bronchial Spasm DISEASE may_treat triamcinolone acetonide MEDRT D003093 Colitis, Ulcerative DISEASE may_treat triamcinolone MEDRT D003093 Colitis, Ulcerative DISEASE may_treat triamcinolone acetonide MEDRT D003874 Dermatitis Herpetiformis DISEASE may_treat triamcinolone MEDRT D003874 Dermatitis Herpetiformis DISEASE may_treat triamcinolone acetonide MEDRT D003876 Dermatitis, Atopic DISEASE may_treat triamcinolone acetonide MEDRT D003876 Dermatitis, Atopic DISEASE may_treat triamcinolone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with triamcinolone acetonide MEDRT D004342 Drug Hypersensitivity DISEASE ci_with triamcinolone MEDRT D004892 Erythema Multiforme DISEASE may_treat triamcinolone MEDRT D004892 Erythema Multiforme DISEASE may_treat triamcinolone acetonide MEDRT D005148 Facial Dermatoses DISEASE may_treat triamcinolone MEDRT D005148 Facial Dermatoses DISEASE may_treat triamcinolone acetonide MEDRT D005533 Foot Dermatoses DISEASE may_treat triamcinolone acetonide MEDRT D005533 Foot Dermatoses DISEASE may_treat triamcinolone MEDRT D006229 Hand Dermatoses DISEASE may_treat triamcinolone MEDRT D006229 Hand Dermatoses DISEASE may_treat triamcinolone acetonide MEDRT D006934 Hypercalcemia DISEASE may_treat triamcinolone acetonide MEDRT D006934 Hypercalcemia DISEASE may_treat triamcinolone MEDRT D007239 Infections DISEASE ci_with triamcinolone acetonide MEDRT D007239 Infections DISEASE ci_with triamcinolone MEDRT D007249 Inflammation DISEASE may_treat triamcinolone acetonide MEDRT D007249 Inflammation DISEASE may_treat triamcinolone MEDRT D007868 Leg Dermatoses DISEASE may_treat triamcinolone acetonide MEDRT D007868 Leg Dermatoses DISEASE may_treat triamcinolone MEDRT D008180 Lupus Erythematosus, Systemic DISEASE may_treat triamcinolone acetonide MEDRT D008180 Lupus Erythematosus, Systemic DISEASE may_treat triamcinolone MEDRT D009103 Multiple Sclerosis DISEASE may_treat triamcinolone MEDRT D009103 Multiple Sclerosis DISEASE may_treat triamcinolone acetonide MEDRT D009181 Mycoses DISEASE ci_with triamcinolone MEDRT D009181 Mycoses DISEASE ci_with triamcinolone acetonide MEDRT D009404 Nephrotic Syndrome DISEASE may_treat triamcinolone acetonide MEDRT D009404 Nephrotic Syndrome DISEASE may_treat triamcinolone MEDRT D010392 Pemphigus DISEASE may_treat triamcinolone MEDRT D010392 Pemphigus DISEASE may_treat triamcinolone acetonide MEDRT D012216 Rheumatic Diseases DISEASE may_treat triamcinolone acetonide MEDRT D012216 Rheumatic Diseases DISEASE may_treat triamcinolone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat triamcinolone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat triamcinolone acetonide MEDRT D012536 Scalp Dermatoses DISEASE may_treat triamcinolone acetonide MEDRT D012536 Scalp Dermatoses DISEASE may_treat triamcinolone MEDRT D012713 Serum Sickness DISEASE may_treat triamcinolone MEDRT D012713 Serum Sickness DISEASE may_treat triamcinolone acetonide MEDRT D013167 Spondylitis, Ankylosing DISEASE may_treat triamcinolone acetonide MEDRT D013167 Spondylitis, Ankylosing DISEASE may_treat triamcinolone MEDRT D013224 Status Asthmaticus DISEASE ci_with triamcinolone MEDRT D013224 Status Asthmaticus DISEASE ci_with triamcinolone acetonide MEDRT D013585 Synovitis DISEASE may_treat triamcinolone acetonide MEDRT D013585 Synovitis DISEASE may_treat triamcinolone MEDRT D013966 Thyroiditis DISEASE may_treat triamcinolone MEDRT D013966 Thyroiditis DISEASE may_treat triamcinolone acetonide MEDRT D014397 Tuberculosis, Pulmonary DISEASE may_treat triamcinolone acetonide MEDRT D014397 Tuberculosis, Pulmonary DISEASE may_treat triamcinolone MEDRT D014605 Uveitis DISEASE may_treat triamcinolone MEDRT D014605 Uveitis DISEASE may_treat triamcinolone acetonide MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa triamcinolone acetonide MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa triamcinolone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa triamcinolone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa triamcinolone acetonide MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe triamcinolone acetonide MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe triamcinolone MEDRT N0000010253 Decreased Capillary Permeability PE has_pe triamcinolone MEDRT N0000010253 Decreased Capillary Permeability PE has_pe triamcinolone acetonide MEDRT N0000008571 Decreased Cytokine Activity PE has_pe triamcinolone acetonide MEDRT N0000008571 Decreased Cytokine Activity PE has_pe triamcinolone MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe triamcinolone MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe triamcinolone acetonide MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe triamcinolone acetonide MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe triamcinolone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe triamcinolone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe triamcinolone acetonide MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe triamcinolone acetonide MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe triamcinolone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe triamcinolone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe triamcinolone acetonide MEDRT N0000008841 Decreased Protein Synthesis PE has_pe triamcinolone acetonide MEDRT N0000008841 Decreased Protein Synthesis PE has_pe triamcinolone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe triamcinolone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe triamcinolone acetonide MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe triamcinolone acetonide MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe triamcinolone MEDRT N0000009741 Lysosomal Function Alteration PE has_pe triamcinolone MEDRT N0000009741 Lysosomal Function Alteration PE has_pe triamcinolone acetonide
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 32 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES VUID 4037017 NAMES Prescribable Synonym triamcinolone acetonide 32 MG Extended-Release Injection SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source Veterans Health Administration National Drug File